A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

Cell Reports - United States
doi 10.1016/j.celrep.2019.08.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence in Vivo

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2012English

In Silico and in Vitro Methods to Identify Ebola Virus VP35-dsRNA Inhibitors

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

Mucosal Priming With a Replicating-Vaccinia Virus-Based Vaccine Elicits Protective Immunity to Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2013English

DNA Vaccines Encoding Proteins From Wild-Type and Attenuated Canine Distemper Virus Protect Equally Well Against Wild-Type Virus Challenge

Archives of Virology
MedicineVirology
2012English

Ebola Virus

Scire Science Newsletter
2018English

Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
2015English

Cross-Protective Immunity Against Influenza a/H1n1 Virus Challenge in Mice Immunized With Recombinant Vaccine Expressing HA Gene of Influenza a/H5n1 Virus

Virology Journal
VirologyInfectious Diseases
2013English

Molecular Dynamics Exploration of the Binding Mechanism and Properties of Single-Walled Carbon Nanotube to WT and Mutant VP35 FBP Region of Ebola Virus

Journal of Biological Physics
Cell BiologyMolecular BiologyMolecular Physics,BiophysicsAtomicOptics
2017English

Ebola Virus

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy